Hydroxychloroquine Sulfate

Hydroxychloroquine is a 4-aminoquinoline compound, structurally a close relative of chloroquine that carries an extra hydroxyl group, which makes it somewhat less toxic. It is supplied as the sulfate salt, hydroxychloroquine sulfate, for oral use. The molecule emerged from mid-twentieth-century antimalarial research; chloroquine was discovered in the 1930s, and hydroxychloroquine was first synthesized in the late 1940s and approved for medical use in the 1950s ^[2]. As a weak base it distributes widely through the body's tissues and has an unusually long half-life measured in weeks, so its effects build up and fade slowly ^[1].

Although it began as a malaria drug, hydroxychloroquine is now used far more often as a disease-modifying antirheumatic drug. It is a first-line, long-term treatment for systemic lupus erythematosus and is widely prescribed in rheumatoid arthritis, discoid lupus, Sjogren's syndrome and antiphospholipid syndrome, where it dampens an overactive immune response and helps prevent disease flares ^[1][2]. In malaria it serves to prevent and to treat infection by chloroquine-sensitive Plasmodium species. It is generally regarded as safe enough to continue during pregnancy in women with autoimmune disease, since large reviews have not linked it to increased birth defects or pregnancy loss ^[3]. Hydroxychloroquine appears on the World Health Organization's List of Essential Medicines. It drew intense public attention in 2020 when it was promoted for COVID-19, but controlled trials found it ineffective for preventing or treating the infection, and emergency authorizations were withdrawn.

Hydroxychloroquine is a prescription medicine taken as oral tablets. It is usually well tolerated, with common complaints including nausea, stomach upset, headache and skin rash, but it carries a distinctive long-term hazard; with years of use and high cumulative exposure the drug can deposit in the retina and cause an irreversible retinopathy, so patients on prolonged therapy undergo periodic eye screening ^[1][2]. Less often it can affect heart rhythm, muscle or the blood, and overdose is dangerous. Because both benefits and toxicities accumulate slowly, treatment is weight-based and monitored over time ^[1].

This is a prescription medicine and is usually well tolerated. The most important long-term risk is retinal damage that depends on dose and duration, which is why doses are kept at or below 5 mg per kg of actual body weight and eyes are screened after about five years of use. Common milder effects include nausea, stomach upset, rash, headache, and skin or hair pigment changes. Rare but serious problems include heart muscle disease, QT prolongation, and low blood counts. It can add to the QT effect of other drugs, raise digoxin levels, and it is generally continued in pregnancy because it is considered safe there.

Hydroxychloroquine prolongs the QT interval, and the interactions that can actually kill are cardiac. Given with azithromycin, fluoroquinolones, amiodarone, sotalol, ondansetron, methadone or antipsychotics such as haloperidol, the effect is additive and the risk of torsades de pointes rises, particularly where hypokalemia or bradycardia is already present.

It raises concentrations of several narrow-index drugs. Digoxin levels climb, with the nausea, visual disturbance and bradyarrhythmia that implies, and ciclosporin levels climb as well. Hydroxychloroquine also inhibits CYP2D6, so substrates of that enzyme accumulate.

Hydroxychloroquine lowers blood glucose in its own right and has caused severe hypoglycemia without any antidiabetic drug present; added to insulin or a sulfonylurea the effect compounds.

Two further points are worth knowing. Antacids raise gastric pH and reduce hydroxychloroquine absorption, which is why the two are conventionally taken about four hours apart. And concurrent tamoxifen raises the risk of hydroxychloroquine retinopathy roughly fivefold, an odds ratio of 4.6 in the largest long-term screening cohort.

Checking a whole stack? Run it through interactions + stacks.

Hydroxychloroquine emerged from the intensive wartime search for improved antimalarial drugs that also produced chloroquine, and it was synthesized in the 1940s as a hydroxylated analogue intended to be less toxic than its predecessor. It reached the market in the United States in 1955 under the brand name Plaquenil, initially as an antimalarial agent. Clinicians soon observed that patients taking it for malaria who also had rheumatic disease experienced improvement in their joint and skin symptoms, an observation that opened its second and now dominant career as a long-acting immunomodulator.

Over subsequent decades it became a cornerstone treatment for systemic lupus erythematosus and rheumatoid arthritis, valued for its favorable safety profile relative to many other disease-modifying drugs. Research clarified its mechanisms in acidic cellular compartments, including interference with Toll-like receptor signaling and antigen presentation. Today it appears on standard treatment guidelines for lupus and is regarded as one of the most important drugs in rheumatology.

Hydroxychloroquine is one of the most valued and enduring drugs in rheumatology, widely considered a cornerstone of care for systemic lupus erythematosus. Contemporary guidelines and reviews recommend that virtually all lupus patients remain on it long term, because it reduces disease flares, protects against organ damage, and is associated with improved survival. Its appeal rests on a combination of meaningful benefit and a comparatively gentle safety profile, allowing use over many years and even, uniquely among lupus therapies, during pregnancy.

Beyond lupus it serves in rheumatoid arthritis and retains its original role in preventing and treating susceptible malaria. In candid terms, its immunomodulatory effects develop gradually over weeks to months, and long-term use requires periodic eye monitoring to guard against a rare retinal toxicity. Weighed overall, its blend of proven disease-modifying benefit, tolerability, and decades of clinical experience secures its place as a genuinely trusted medicine.